Avalo Therapeutics Inc (AVTX)

NASDAQ · Biotechnology

6.93
-0.52 (-6.98%)
Updated Oct 24, 2:29 AM ET
AI Rating
Sell
Overall Score
34
Trend
30
Momentum
34
Risk
42

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Oct 7, 2025 260 sessions Oct 19, 2026

AI Analysis

Avalo Therapeutics Inc is trading at $6.93, down 6.98% on the session. The 50 day average sits at $16.84 and the 200 day at $16.41, which puts the stock in a uptrend. RSI is at 25.1, which reads as oversold, and MACD is bearish crossover. Volume is volume spike.

The nearest support is around $11.21 with resistance near $15.99, so that band frames the current range. Average daily movement is roughly $0.84, or about 12.2% of the share price, which is what any stop placement has to allow for. The overall health score of 34 out of 100 combines a trend score of 30, momentum of 34 and a risk score of 42.

Technical indicators

RSI (14)
25.1
oversold
MACD
-1.467
bearish crossover
SMA 20
13.99
SMA 50
16.84
SMA 200
16.41
uptrend
ATR (14)
0.84
avg daily range
Support
11.21
Resistance
15.99
Volume vs 20d
2.19x
volume spike
Volatility
58.9%
annualised
1 month
-30.05%
3 months
-38.42%

AI trade signals on AVTX

All signals
Date Setup Entry Target Stop R:R Status
Aug 20 Breakout ••.•• ••.•• ••.•• 1.61:1 Expired

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.